ENGERIX-B MCG

Main information

  • Trade name:
  • ENGERIX-B MCG 0.5ML INJ
  • Dosage:
  • 10MCG
  • Pharmaceutical form:
  • INJ
  • Composition:
  • 0.5ML
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ENGERIX-B MCG 0.5ML INJ
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

29-6-2018

Nieuwe behandeling tegen hepatitis C in het basispakket

Nieuwe behandeling tegen hepatitis C in het basispakket

Een nieuwe behandeling tegen chronische hepatitis C met het geneesmiddel Vosevi wordt vanaf 1 juli 2018 vergoed vanuit het basispakket. Dat heeft minister Bruno Bruins (Medische Zorg) besloten nadat hij met de fabrikant onderhandeld heeft over de prijs van het nieuwe middel. Vosevi kan worden ingezet bij alle patiënten met een chronische hepatitis C infectie. Met de opname van Vosevi zijn nu alle geneesmiddelen voor hepatitis C patiënten in Nederland beschikbaar vanuit het basispakket .

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

31-5-2018

Apotex Corp. Issues Voluntary Nationwide Recall of Fluticasone Propionate Nasal Spray USP 50 mcg Per Spray 120 Metered Sprays Due to Potential for Small Glass Particles

Apotex Corp. Issues Voluntary Nationwide Recall of Fluticasone Propionate Nasal Spray USP 50 mcg Per Spray 120 Metered Sprays Due to Potential for Small Glass Particles

Apotex Corp. is voluntarily recalling one (1) lot of Fluticasone Propionate Nasal Spray, USP, 50 mcg per spray, 120 Metered Sprays, to the consumer level. The Fluticasone Propionate Nasal Spray USP 50 mcg per spray 120 Metered Sprays has been found to contain small glass particles. The glass particles could block the actuator and impact the functionality of the pump. The issue was discovered through a customer complaint.

FDA - U.S. Food and Drug Administration

27-4-2018

EpiPen 300 mcg adrenaline auto-injector

EpiPen 300 mcg adrenaline auto-injector

Medicine shortages

Therapeutic Goods Administration - Australia

19-4-2018

Fluad trivalent influenza vaccine

Fluad trivalent influenza vaccine

Safety advisory - risk to patients with latex allergy

Therapeutic Goods Administration - Australia

27-3-2018

Flu vaccine: 2018 seasonal influenza vaccines for use in children

Flu vaccine: 2018 seasonal influenza vaccines for use in children

Information about influenza vaccines for use in 2018

Therapeutic Goods Administration - Australia

16-11-2017

Medicines Safety Update, Volume 8, Number 5, October-November 2017

Medicines Safety Update, Volume 8, Number 5, October-November 2017

Ibrutinib - ventricular tachyarrhythmia, hepatitis B reactivation and infection; Improving Product Information; Codeine-containing products - use in children and ultra-rapid metabolisers

Therapeutic Goods Administration - Australia

30-11-2016

How the HPV vaccine works

How the HPV vaccine works

The Danish Medicines Agency has made a short video graphic about the efficacy of the HPV vaccine.

Danish Medicines Agency

3-5-2016

New video graphics about the HPV vaccine

New video graphics about the HPV vaccine

The Danish Medicines Agency has made a video which explains how the authorities monitor the safety of the HPV vaccine.

Danish Medicines Agency

9-2-2016

EMA: No changes to the safety profile of Gardasil

EMA: No changes to the safety profile of Gardasil

The European Medicines Agency (EMA) has recently completed its annual routine safety assessment of the HPV vaccine Gardasil®. The conclusion is that there are no changes to the safety profile.

Danish Medicines Agency

17-4-2015

EMA's new assessment of the HPV vaccine: The benefits outweigh the risks

EMA's new assessment of the HPV vaccine: The benefits outweigh the risks

A causal relationship between the dizziness and fatigue syndrome, Postural Orthostatic Tachycardia Syndrome (POTS) and Gardasil can neither be confirmed nor denied. The EU's group of pharmacovigilance experts have made a new assessment of the vaccine and still consider it to be safe.

Danish Medicines Agency

4-3-2015

The MMR vaccine is a safe vaccine

The MMR vaccine is a safe vaccine

We have reviewed the reported adverse reactions from the MMR vaccine during the past five years.

Danish Medicines Agency

14-7-2014

Danish Pharmacovigilance Update May 2014

Danish Pharmacovigilance Update May 2014

In the May issue of Danish Pharmacovigilance Update: Assessment of risk of serious anaphylactic reactions from treatment with ferumoxytol (Rienso), ADR reports for the HPV vaccine and the Danish Health and Medicines Authority’s annual pharmacovigilance report 2013.

Danish Medicines Agency

24-3-2011

Danish Pharmacovigilance Update, 17 March 2011

Danish Pharmacovigilance Update, 17 March 2011

This month’s issue of Danish Pharmacovigilance Update includes articles about reports of serious side effects in Japan from the childhood vaccines Prevenar (PCV7)® and Act-Hib® and reports of serious side effects in France from the childhood vaccine Prevenar13®.

Danish Medicines Agency

29-6-2018

Porcilis PCV M Hyo (Intervet International B.V.)

Porcilis PCV M Hyo (Intervet International B.V.)

Porcilis PCV M Hyo (Active substance: Porcine circovirus and Mycoplasma hyopneumoniae vaccine (inactivated)) - Centralised - 2-Monthly update - Commission Decision (2018)4166 of Fri, 29 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/3796/II/7

Europe -DG Health and Food Safety

29-6-2018

Evalon (Laboratorios Hipra, S.A.)

Evalon (Laboratorios Hipra, S.A.)

Evalon (Active substance: Coccidiosis vaccine live for chickens) - Centralised - Yearly update - Commission Decision (2018)4165 of Fri, 29 Jun 2018

Europe -DG Health and Food Safety

20-6-2018

Rhiniseng (Laboratorios Hipra, S.A.)

Rhiniseng (Laboratorios Hipra, S.A.)

Rhiniseng (Active substance: inactivated vaccine against atrophic rhinitis in pigs) - Centralised - Yearly update - Commission Decision (2018)3952 of Wed, 20 Jun 2018

Europe -DG Health and Food Safety

11-6-2018

Bexsero (GlaxoSmithKline Vaccines S.r.l.)

Bexsero (GlaxoSmithKline Vaccines S.r.l.)

Bexsero (Active substance: Meningococcal group B Vaccine (rDNA, component, adsorbed)) - Centralised - 2-Monthly update - Commission Decision (2018)3769 of Mon, 11 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2333/II/59

Europe -DG Health and Food Safety

28-5-2018

News and press releases:  Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 23–25 May 2018

News and press releases: Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 23–25 May 2018

New vaccine to reduce the incidence of intramammary infections in cows/heifers recommended for approval

Europe - EMA - European Medicines Agency

15-5-2018

Aflunov (Seqirus S.r.l.)

Aflunov (Seqirus S.r.l.)

Aflunov (Active substance: Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)) - Centralised - Yearly update - Commission Decision (2018)3066 of Tue, 15 May 2018

Europe -DG Health and Food Safety

30-4-2018

News and press releases:  Update of EU recommendations for 2018/2019 seasonal flu vaccine composition

News and press releases: Update of EU recommendations for 2018/2019 seasonal flu vaccine composition

Update to recommendations issued in March 2018

Europe - EMA - European Medicines Agency

9-2-2018

Suvaxyn Circo (Zoetis Belgium S.A.)

Suvaxyn Circo (Zoetis Belgium S.A.)

Suvaxyn Circo (Active substance: Porcine circovirus vaccine (inactivated, recombinant)) - New authorisation - Commission Decision (2018)861 of Fri, 09 Feb 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/4242

Europe -DG Health and Food Safety

5-12-2017

Rabitec (IDT Biologika GmbH)

Rabitec (IDT Biologika GmbH)

Rabitec (Active substance: Rabies vaccine (live, oral) for foxes and raccoon dogs) - New authorisation - Commission Decision (2017)1365 of Tue, 05 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/V/C/4387

Europe -DG Health and Food Safety